Yahoo
NYSE - Nasdaq Real Time Price USD

Envista Holdings Corporation (NVST)

26.40 -0.62 (-2.29%)
As of 10:41:08 AM EDT. Market Open.
Trade NVST on Coinbase
Chart Range Bar
Loading chart for NVST
  • Previous Close 27.02
  • Open 26.75
  • Bid 26.34 x 10000
  • Ask 26.36 x 10000
  • Day's Range 26.24 - 26.75
  • 52 Week Range 18.77 - 30.42
  • Volume 381,440
  • Avg. Volume 3,031,896
  • Market Cap (intraday) 4.296B
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) 64.39
  • EPS (TTM) 0.41
  • Earnings Date (est.) Aug 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 29.69

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

envistaco.com

12,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 6/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NVST
21.60%
S&P 500 (^GSPC)
9.17%

1-Year Return

NVST
35.11%
S&P 500 (^GSPC)
20.44%

3-Year Return

NVST
21.99%
S&P 500 (^GSPC)
67.93%

5-Year Return

NVST
38.90%
S&P 500 (^GSPC)
73.90%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 705.5M
Earnings 60M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
200M
400M
600M

Analyst Insights

View More

Analyst Price Targets

21.00 Low
29.69 Average
26.40 Current
35.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/11/2026
Analyst Barclays
Rating Action Maintains
Rating Overweight
Price Action Lowers
Price Target 34 -> 32

Statistics

View More

Valuation Measures

Annual
As of 6/29/2026
  • Market Cap

    4.40B

  • Enterprise Value

    4.90B

  • Trailing P/E

    65.90

  • Forward P/E

    20.33

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.61

  • Price/Book (mrq)

    1.43

  • Enterprise Value/Revenue

    1.75

  • Enterprise Value/EBITDA

    12.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.41%

  • Return on Assets (ttm)

    3.01%

  • Return on Equity (ttm)

    2.21%

  • Revenue (ttm)

    2.81B

  • Net Income Avi to Common (ttm)

    67.7M

  • Diluted EPS (ttm)

    0.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.08B

  • Total Debt/Equity (mrq)

    51.61%

  • Levered Free Cash Flow (ttm)

    216.34M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

26.40 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • What does Argus have to say about NVST?

    ENVISTA HOLDINGS CORP has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about NVST?

    ENVISTA HOLDINGS CORP has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • Rating decreased to a SELL

    ENVISTA HOLDINGS CORP has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $22.00

    ENVISTA HOLDINGS CORP has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: